Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum
- PMID: 15286229
- DOI: 10.1542/peds.114.2.451
Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum
Abstract
Objective: Cryptic subtelomeric chromosome rearrangements account for 6% to 10% of idiopathic mental retardation. As cytogenetic and molecular techniques have become more sophisticated, the number of genetic syndromes attributed to these microdeletions has increased. To date, 64 patients have been described in the literature with a more recently recognized microdeletion syndrome, del 22q13.3. The purpose of this study is to present 11 new cases of this recently described syndrome to delineate further the phenotype and to alert the clinician to another genetic condition that should be considered in the differential diagnosis of early hypotonia, delayed speech acquisition, and autistic behavior.
Methods: Eleven patients were evaluated in 3 academic institutions. Clinical features and results of cytogenetic testing were recorded and tabulated. Reasons for referral for genetic evaluation included developmental delay, severe expressive speech and language delay, and dysmorphic features.
Results: Age of presentation ranged from 5 months to 46 years. There were 10 female patients and 1 male patient. All of the patients exhibited delayed motor development, some degree of hypotonia, and severe expressive speech and language delay. Dysmorphic facial features included epicanthal folds, large cupped ears, underdeveloped philtrum, loss of cupid's bow, and full supraorbital ridges. Six patients exhibited autistic-like behaviors. Microscopically visible chromosome deletions were observed in 6 patients. In the remainder, the deletion was detected with the use of fluorescence in situ hybridization.
Conclusions: Hypotonia and developmental delay are nonspecific findings observed in many malformation and genetic syndromes. However, in association with severe speech and language delay and autistic-like behavior, this phenotype may be a significant indication to consider the 22q13 deletion syndrome as a potential cause.
Comment in
-
Stephanie's story: caring for a child with terminal 22q deletion syndrome.Pediatrics. 2005 Feb;115(2):512. doi: 10.1542/peds.2004-2467. Pediatrics. 2005. PMID: 15687465 No abstract available.
Similar articles
-
Deletion 22q13.3 syndrome.Orphanet J Rare Dis. 2008 May 27;3:14. doi: 10.1186/1750-1172-3-14. Orphanet J Rare Dis. 2008. PMID: 18505557 Free PMC article.
-
22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.Am J Med Genet C Semin Med Genet. 2007 Nov 15;145C(4):393-8. doi: 10.1002/ajmg.c.30155. Am J Med Genet C Semin Med Genet. 2007. PMID: 17926345 Review.
-
Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).J Med Genet. 2011 Nov;48(11):761-6. doi: 10.1136/jmedgenet-2011-100225. Epub 2011 Oct 7. J Med Genet. 2011. PMID: 21984749
-
[Muscular hypotonia, developmental retardation, speech delay and mildly dysmorphic features: 22q13 deletion syndrome (Phelan-McDermid Syndrome) as an important differential diagnosis].Klin Padiatr. 2008 Sep-Oct;220(5):318-20. doi: 10.1055/s-2007-977733. Klin Padiatr. 2008. PMID: 18814345 German.
-
Case with autistic syndrome and chromosome 22q13.3 deletion detected by FISH.Am J Med Genet. 2000 Dec 4;96(6):839-44. Am J Med Genet. 2000. PMID: 11121193 Review.
Cited by
-
A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders.Dev Neurobiol. 2014 Feb;74(2):136-46. doi: 10.1002/dneu.22089. Epub 2013 Sep 11. Dev Neurobiol. 2014. PMID: 23650259 Free PMC article. Review.
-
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).Mol Syndromol. 2012 Apr;2(3-5):186-201. doi: 10.1159/000334260. Epub 2011 Nov 22. Mol Syndromol. 2012. PMID: 22670140 Free PMC article.
-
Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome.Mol Syndromol. 2020 Jan;10(6):294-305. doi: 10.1159/000503840. Epub 2019 Nov 5. Mol Syndromol. 2020. PMID: 32021603 Free PMC article.
-
Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients.Mol Brain. 2014 Sep 3;7:64. doi: 10.1186/s13041-014-0064-z. Mol Brain. 2014. PMID: 25182223 Free PMC article. Review.
-
Sociability and motor functions in Shank1 mutant mice.Brain Res. 2011 Mar 22;1380:120-37. doi: 10.1016/j.brainres.2010.09.026. Epub 2010 Sep 21. Brain Res. 2011. PMID: 20868654 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials